Dow Up 0.26% Nasdaq Up 0.15%

Seattle Genetics Inc. (SGEN)

-NMS
36.94 Down 1.45(3.78%) 12:05PM EDT - Nasdaq Real Time Price
Prev Close:38.39
Open:37.00
Bid:36.87 x 100
Ask:36.89 x 100
1y Target Est:44.75
Beta:1.28
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:36.26 - 37.62
52wk Range:32.35 - 55.99
Volume:1,163,933
Avg Vol (3m):956,278
Market Cap:4.56B
P/E (ttm):N/A
EPS (ttm):-0.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SGEN

Comparison

Symbol% ChgMkt Cap
SGENDown 3.78%4.56B
IMGNDown 2.62%934.44M
PFEUp 0.34%189.40B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-6.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback